Webcast - 2021 BCMA-Directed Therapies in Multiple Myeloma

This accredited continuing education activity “Webcast - 2021 BCMA-Directed Therapies in Multiple Myeloma," is recorded from the live oncology webinar held on 12/04/2021. 

If you participated in the live oncology webinar titled - 2021 BCMA-Directed Therapies in Multiple Myeloma on 12/04/2021 and claimed CME credits/MOC points for that activity, you do not qualify for CME credits/MOC points for your participation in this enduring activity. This is a recorded content from that webinar on 12/04/2021.  However, you may enroll in this activity to review the contents. 

2021 BCMA Directed Therapies in Multiple Myeloma, is a CME-accredited, half-day oncology conference featuring leading experts in multiple myeloma who will provide a comprehensive overview of current state and the future implications of B-cell Maturation Antigen (BCMA) directed therapies in multiple myeloma (MM). The goal of this activity is to improve the knowledge and the competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with MM. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in MM focusing on multiple immunotherapeutic options with BCMA as the lead target. Expert faculty will utilize didactics, case-based presentations, and related panel discussions on several current and emerging BCMA directed therapies including bispecific antibodies, CART and ADC available for MM patients, and how to sequence them in an effective manner to provide the best outcomes. The Binaytara Foundation will utilize a virtual format that includes both online recorded materials and live web-based interactive discussions to provide an easily accessible environment for learning, engagement, and dialogue with peers and presenters. 

REGISTRATION FEES:

This activity is free for all healthcare providers who are not employees of an ineligible entity. Please select "non-industry learner" when you are ready to register for the course, and the price will reset to $0. 

Healthcare providers ($0.00)

Industry employees ($200 + 3% Credit card fee) 

If you are a healthcare provider involved in patient care and you are not employed by the Industry, then you don't pay anything to register for this activity.

If you are employed by industry, you must pay a registration fee to participate in these meetings. Any unpaid industry registrations will be invoiced $412 per participant.

If you paid to join the live meeting associated with this webcast and wish to register for this enduring material please contact us and we will register you for free.

Target Audience

  • Cancer care professionals
  • Practicing hematologists and oncologists
  • Oncology fellows
  • Oncology nurses
  • Oncology nurse practitioners
  • Oncology physician assistants
  • Oncology pharmacists

Learning Objectives

Upon successful completion of this educational activity, participants will be able to:

  • Review the mechanism of resistance and determinants of response to BCMA directed therapies
  • Describe the role, including efficacy and adverse events, of BCMA-directed CAR-T therapy in MM
  • Outline the role, including efficacy and adverse events, of BMCA directed BsB and ADC in MM.
  • Integrate BCMA directed therapies in the management of relapsed and/or refractory MM
  • Identify and manage adverse events from BCMA directed therapies
Course summary
Available credit: 
  • 2.50 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.50 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 2.50 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 2.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 2.50 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 0.00 Attendance
  • 2.50 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 2.50 Contact Hours.
Course opens: 
12/06/2021
Course expires: 
12/09/2022
Cost:
$1.00

This educational activity features recorded videos from the live webinar titled - 2021 BCMA-Directed Therapies in Multiple Myeloma.

The videos are placed in the following order. Feel free to view the content that is relevant to you.

Participants should claim continuing education credits to the extent of their participation.


Conference Chair: Binod Dhakal, MD, MS


Moderator: Dinesh Bhurani, MBBS, MD, DM, FRCPA

30 minutes: BCMA CAR-T in MM: Current state and future implications - Adam Sperling, MD, PhD

30 minutes: Role of BCMA bispecific antibodies in MM - Alfred L. Garfall, MD


Moderator: Dinesh Bhurani, MBBS, MD, DM, FRCPA

30 minutes: Optimal sequencing of CAR-T vs. bispecific antibodies and other immune therapies in MM - Surbhi Sidana, MD 

30 minutes: Understanding the determinants of response and mechanism of resistance to BCMA targeted agents - Krina Patel, MD, MSc

30 minutes: Case-based discussion - Binod Dhakal, MD, MS

Moderator(s)

DINESH BHURANI, Dr. Dinesh Bhurani

has no relevant financial relationships to disclose at this time.
Speaker(s)

Binod Dhakal, MD, MS

has a financial relationship (Other) with GSK;.
has a financial relationship (Other) with Natera;.
has a financial relationship (Other) with Sanofi;.
has a financial relationship (Other) with Celgene/BMS;.
has a financial relationship (Other) with Janssen;.
has a financial relationship (Other) with Amgen;.

Alfred Garfall, MD

has a financial relationship (Grant Or Contract) with Janssen;.
has a financial relationship (Grant Or Contract) with CRISPR Therapeutics;.
has a financial relationship (Grant Or Contract) with Novartis;.
has a financial relationship (Independent contractor) with Janssen;.
has a financial relationship (Grant Or Contract) with Tmunity;.
has a financial relationship (Independent contractor) with Amgen;.

Krina Patel, MD

has a financial relationship (Independent contractor) with Pfizer;.
has a financial relationship (Independent contractor) with Legend Biotech;.
has a financial relationship (Independent contractor) with BMS;.
has a financial relationship (Independent contractor) with Janssen;.

Surbhi Sidana, MD

has a financial relationship (Professional Services) with Magenta Therapeutcs, BMS, Janssen, Sanofi, Oncopeptides;.
has a financial relationship (Grant Or Contract) with Magenta Therapeutics, BMS, Allogene, Janssen;.

Adam Sperling, MD, PhD

has a financial relationship (Other) with Adaptive;.

Important Information about Claiming CME for this activity:

If you participated in the live webinar titled - 2021 BCMA-Directed Therapies in Multiple Myeloma on 12/04/2021 and claimed CME credits/MOC points for that activity, you do not qualify for CME credits/MOC points for your participation in this enduring activity. This is a recorded content from that webinar on 12/04/2021. However, you can still enroll in this activity and review the contents as needed.

The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians.

Available Credit

  • 2.50 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.50 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 2.50 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 2.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 2.50 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 0.00 Attendance
  • 2.50 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 2.50 Contact Hours.

Price

Cost:
$1.00
Please login or register to take this course.

REGISTRATION FEES:

This activity is free for all healthcare providers who are not employees of an ineligible entity. Please select "non-industry learner" when you are ready to register for the course, and the price will reset to $0. 

Healthcare providers ($0.00)

Industry employees ($200 + 3% Credit card fee) 

If you are a healthcare provider involved in patient care and you are not employed by the Industry, register for free!

If you are employed by industry, you must pay a registration fee to participate in these meetings. Any unpaid industry registrations will be invoiced $412 per participant.

If you paid to join the live meeting and wish to register for this enduring material please contact us and we will register you for free.

Cancellation Policy

You may cancel your enrollment at any time. No credits will be offered if you do not complete all required steps of this activity which include registration, watching the recorded content, and completion of pre & post tests as well as course evaluations.

Refund Policy 

This activity is free for all healthcare providers who are not employees of an ineligible entity.

No refunds will be issued if you have started watching the recorded content.